GLIMEPIRIDE (GLIMEPIRIDE) — FDA Approval ANDA077624 (QUAGEN)
GLIMEPIRIDE (GLIMEPIRIDE) — FDA Approval ANDA077624 (QUAGEN) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: GLIMEPIRIDE; Active ingredients: GLIMEPIRIDE; Application number: ANDA077624.
| Brand name | GLIMEPIRIDE |
|---|---|
| Active ingredients | GLIMEPIRIDE |
| Application number | ANDA077624 |
| Sponsor | QUAGEN |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 3 |
| First approval date | 20051128 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →